Medpace Holdings, Inc. 8-K

What Happened Medpace Holdings, Inc. filed an 8-K (Item 5.02) reporting that, effective June 1, 2026, it appointed Brad W. Hansman (age 43) as Executive Vice President, Operations. Mr. Hansman will perform the functions of the company’s principal operating officer alongside Susan E. Burwig. He joined Medpace in April 2011, has held finance and multiple operations leadership roles since 2015, and previously worked as an audit supervisor and auditor earlier in his career.

Key Details

• Effective date: June 1, 2026.
• Base salary: $492,250 per year.
• Incentives: Eligible for the short-term incentive (cash bonus) plan and the long-term equity incentive plan at the Compensation Committee’s discretion.
• Background: With Medpace since 2011; roles included Executive Director, VP, and SVP overseeing study start-up, logistics, regulatory affairs, and medical writing. Holds a BBA in Accounting and is an inactive CPA.
• Governance: No family relationships with current executives or directors, no reportable related-party transactions, and he was not appointed under any third-party arrangement; he entered the company’s standard indemnification agreement.

Why It Matters This is a senior operating leadership change that formalizes Mr. Hansman’s role as a principal operating officer, which could affect operational oversight and execution of clinical study services. For investors, the filing provides clear compensation terms and governance disclosures (no related-party concerns). The appointment signals continuity by promoting an internal leader with long tenure in operations and finance.